BLACK CYBER WEEK! Publikacje i multimedia nawet do 80% taniej i darmowa dostawa od 350 zł! Sprawdź >
Autorzy konsensusu uważają, że powyższe stwierdzenia stanowić będą wskazówki dla psychiatrów, aby stosowanie przez nich leków przeciwdepresyjnych w ChAD przyniosło największe korzyści dla pacjentów.
Piśmiennictwo
1. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, DSM-5, American Psychiatric Association, Arlington, VA, 2013
2. Diagnostic and Statistical Manual of Mental Disorders Fourth Edition, DSM-IV, American Psychiatric Association, Washington, DC, 1994
3. Fava GA, Kellner R. Staging: a neglected dimension in psychiatric classification. Acta Psychiatr. Scand. 1993; 87: 225–230
4. Wright JR, Jr. Albert C. Broders’ paradigm shifts involving the prognostication and definition of cancer. Arch Pathol Lab Med 2012; 136: 1437-1446
5. Ferensztajn E, Rybakowski J. Etapy przebiegu choroby afektywnej dwubiegunowej. Psychiatr Pol 2012; 46: 613-626
6. Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am. J. Psychiatry. 1992; 149: 999–1010
7. Berk M, Hallam KT, McGorry PD. The potential utility of a staging model as a course specifier: a bipolar disorder perspective. J Affect Disord. 2007; 100: 279-281
8.Kapczinski F, Dias VV, Kauer-Sant‘Anna M, Frey BN, Grassi-Oliveira R, Colom F i wsp. Clinical implications of a staging model for bipolar disorders. Expert Rev Neurother. 2009; 9: 957–966
9. Duffy A. The early natural history of bipolar disorder: what we have learned from longitudinal high-risk research. Can J Psychiatry. 2010; 55: 477- 485
10. Angst J. The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord 1998; 50: 143-151
11. Hirschfeld RMA, Williams JBW, Spitzer RL, Calabrese JR, Flynn L, Keck PE i wsp. Development and validation of a screening instrument for bipolar spectrum disorder: The Mood Disorder Questionnaire. Am J Psychiatry 2000; 157: 1873-1875
12. Angst J, Adolfsson R, Benazzi F, Gamma A, Hantouche E, Meyer TD i wsp. The HCL-32: towards a self-assessment tool for hypomanic symptoms in outpatients. J Affect Disord 2005; 88: 217-233
13. Zimmermann P, Brückl T, Nocon A, Pfister H, Lieb R, Wittchen HU i wsp. Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity. Arch Gen Psychiatry 2009; 66: 1341-1352
14. Angst J, Azorin JM, Bowden CL, Perugi G, Vieta E, Gamma A i wsp. Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode. Arch Gen Psychiatry 2011; 68: 791-798
15. Rybakowski JK, Dudek D, Pawłowski T, Łojko D, Siwek M, Kiejna A. Use of the Hypomania Checklist-32 and The Mood Disorder Questionnaire for detecting bipolarity in 1,051 patients with major depressive disorder. Eur Psychiatry 2012; 27: 577-581
16. Rybakowski JK. Bipolarity and inadequate response to antidepressant drugs. Clinical and psychopharmacological perspective. J Affect Disord 2011; 136: e13-e19
17. Rybakowski JK. Two generations of mood stabilizers. Int J Neuropsychopharmacol 2007; 10: 709-711
18. Pacchiarotti I, Bond DJ, Baldessarini RJ, Nolen WA, Grunze H, Licht RW i wsp. The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry 2013; 170: 1249-1262